JP6306782B2 - Abcトランスポーター阻害剤 - Google Patents
Abcトランスポーター阻害剤 Download PDFInfo
- Publication number
- JP6306782B2 JP6306782B2 JP2017127860A JP2017127860A JP6306782B2 JP 6306782 B2 JP6306782 B2 JP 6306782B2 JP 2017127860 A JP2017127860 A JP 2017127860A JP 2017127860 A JP2017127860 A JP 2017127860A JP 6306782 B2 JP6306782 B2 JP 6306782B2
- Authority
- JP
- Japan
- Prior art keywords
- nitroimidazole
- dihydroxy
- abc transporter
- drug
- hydroxymethylpropyloxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
<2>抗ガン剤とともに使用されることを特徴とする、<1>に記載の低酸素条件下でのABCトランスポーター阻害剤。
<3>低酸素条件下での薬剤排出抑制剤である、<1>又は<2>に記載のABCトランスポーター阻害剤。
<4>上記に構造式を示す、1−(2,3−ジヒドロキシ−1−ヒドロキシメチルプロピルオキシメチル)−2−ニトロイミダゾールからなり、抗ガン剤耐性癌の治療に用いられることを特徴とする、低酸素条件下での薬剤効果増強剤。
<5>抗ガン剤とともに使用されることを特徴とする、<4>に記載の薬剤効果増強剤。
Claims (5)
- 抗ガン剤とともに使用されることを特徴とする、請求項1に記載の低酸素条件下でのABCトランスポーター阻害剤。
- 低酸素条件下での薬剤排出抑制剤である、請求項1又は2に記載のABCトランスポーター阻害剤。
- 抗ガン剤とともに使用されることを特徴とする、請求項4に記載の薬剤効果増強剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017127860A JP6306782B2 (ja) | 2017-06-29 | 2017-06-29 | Abcトランスポーター阻害剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017127860A JP6306782B2 (ja) | 2017-06-29 | 2017-06-29 | Abcトランスポーター阻害剤 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013080745A Division JP6170327B2 (ja) | 2013-03-22 | 2013-03-22 | Abcトランスポーター阻害剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017206538A JP2017206538A (ja) | 2017-11-24 |
JP6306782B2 true JP6306782B2 (ja) | 2018-04-04 |
Family
ID=60414774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017127860A Active JP6306782B2 (ja) | 2017-06-29 | 2017-06-29 | Abcトランスポーター阻害剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6306782B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6652541B2 (ja) | 2017-10-25 | 2020-02-26 | 矢崎総業株式会社 | 電気接続箱 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5929104A (en) * | 1997-04-02 | 1999-07-27 | Pola Chemical Industries, Inc. | Method for inducing apoptosis of cancer cell |
JP2007230958A (ja) * | 2006-03-03 | 2007-09-13 | Pola Chem Ind Inc | 低酸素性細胞放射線増感剤における放射線増感能の増強剤 |
JP2007302609A (ja) * | 2006-05-12 | 2007-11-22 | Pola Chem Ind Inc | 低酸素性細胞放射線増感剤における放射線増感能の増強剤 |
CN101642452B (zh) * | 2008-08-06 | 2014-05-28 | 株式会社宝丽制药 | 脑肿瘤用放射线敏化剂 |
-
2017
- 2017-06-29 JP JP2017127860A patent/JP6306782B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017206538A (ja) | 2017-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6147799B2 (ja) | Parpインヒビターとの組合せ療法 | |
Trouve et al. | Nitrendipine: an antidote to cardiac and lethal toxicity of cocaine | |
CN109562080B (zh) | 用于治疗癌症和癌症并发症的药物组合物 | |
US20160324829A1 (en) | Combination therapy with parp inhibitors | |
CA3138197A1 (en) | Anti-cancer nuclear hormone receptor-targeting compounds | |
US20150005354A1 (en) | Combination Therapy With Parp Inhibitors | |
JP2014511365A5 (ja) | ||
JP6306782B2 (ja) | Abcトランスポーター阻害剤 | |
JP5289310B2 (ja) | 微小管破壊剤及びそれを含有する癌細胞増殖抑制剤 | |
RU2712448C1 (ru) | Способ кардиопротекции ишемических и реперфузионных повреждений в остром периоде инфаркта миокарда | |
JP6170327B2 (ja) | Abcトランスポーター阻害剤 | |
JP6462147B2 (ja) | Hsp90阻害ペプチド結合体及びその腫瘍治療における応用 | |
US9376432B2 (en) | Use of VEGFR-3 inhibitors for treating hepatocellular carcinoma | |
KR20150083353A (ko) | 경요도적 주입용 방광암 예방 또는 치료를 위한 약제학적 조성물 | |
KR20180013758A (ko) | 혈관차단제를 포함하는 간암 치료용 조성물 | |
US20190175566A1 (en) | Anti-tumor cocktail comprising an anti-tumor agent selective for tumor acidity, an antioxidant, and a p-glycoprotein inhibitor | |
JP2014221752A (ja) | ガン幹細胞に対する分化促進薬及び脳腫瘍治療薬 | |
CN102319260A (zh) | 顺铂联合伊曲康唑异构体在制备治疗肺癌药物中的应用 | |
KR100697312B1 (ko) | 세프트리악손을 포함하는 stat3 활성 저해 활성을가지는 조성물 | |
US20080280867A1 (en) | Combination therapy with parp inhibitors | |
US20170087120A1 (en) | Composition for improving bioavailbility and efficacy of taxane | |
JP5955531B2 (ja) | 抗癌剤 | |
US20240139113A1 (en) | Lipid nanoparticle with target integrin function and uses thereof | |
CN111494371B (zh) | Pyr3的用途 | |
US20190290657A1 (en) | Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20171012 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20180227 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20180308 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6306782 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |